BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32949967)

  • 21. Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study.
    Martin E; Coert JH; Flucke UE; Slooff WM; van de Sande MAJ; van Noesel MM; Grünhagen DJ; Wijnen MHWA; Verhoef C
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28138. PubMed ID: 31889416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
    van Noesel MM; Orbach D; Brennan B; Kelsey A; Zanetti I; de Salvo GL; Gaze MN; Craigie RJ; McHugh K; Francotte N; Collini P; Bisogno G; Casanova M; Ferrari A
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27833. PubMed ID: 31241238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.
    Agresta L; Salloum R; Hummel TR; Ratner N; Mangano FT; Fuller C; McMasters RL; Pater L; Jones BV; Szabo S; Pressey JG
    Pediatr Blood Cancer; 2019 Feb; 66(2):e27520. PubMed ID: 30408304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.
    Shurell-Linehan E; DiPardo BJ; Elliott IA; Graham DS; Eckardt MA; Dry SM; Nelson SD; Singh AS; Kalbasi A; Federman N; Bernthal NM; Eilber FC
    Am J Clin Oncol; 2019 May; 42(5):426-431. PubMed ID: 30913092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High grade malignant peripheral nerve sheath tumors: outcome of 62 patients with localized disease and review of the literature.
    Longhi A; Errani C; Magagnoli G; Alberghini M; Gambarotti M; Mercuri M; Ferrari S
    J Chemother; 2010 Dec; 22(6):413-8. PubMed ID: 21303750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database.
    Le Guellec S; Decouvelaere AV; Filleron T; Valo I; Charon-Barra C; Robin YM; Terrier P; Chevreau C; Coindre JM
    Am J Surg Pathol; 2016 Jul; 40(7):896-908. PubMed ID: 27158754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Kahn J; Gillespie A; Tsokos M; Ondos J; Dombi E; Camphausen K; Widemann BC; Kaushal A
    Front Oncol; 2014; 4():324. PubMed ID: 25452937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Meister MT; Scheer M; Hallmen E; Stegmaier S; Vokuhl C; von Kalle T; Fuchs J; Münter M; Niggli F; Ladenstein R; Kazanowska B; Ljungman G; Bielack S; Koscielniak E; Klingebiel T;
    J Surg Oncol; 2020 Dec; 122(7):1337-1347. PubMed ID: 32812260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.
    Graham DS; Russell TA; Eckardt MA; Motamedi K; Seeger LL; Singh AS; Bernthal NM; Kalbasi A; Dry SM; Nelson SD; Elashoff D; Levine BD; Eilber FC
    Am J Clin Oncol; 2019 Oct; 42(10):739-743. PubMed ID: 31436746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of mast cell and microvascular densities in malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.
    Vasconcelos RAT; Guimarães Coscarelli P; Vieira TM; Noguera WS; Rapozo DCM; Acioly MA
    Cancer Med; 2019 Mar; 8(3):972-981. PubMed ID: 30735009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
    Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
    J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors-A Sarcoma Reference Center Experience.
    Sobczuk P; Teterycz P; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Kozak K; Falkowski S; Rutkowski P
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 33003503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review.
    Zehou O; Fabre E; Zelek L; Sbidian E; Ortonne N; Banu E; Wolkenstein P; Valeyrie-Allanore L
    Orphanet J Rare Dis; 2013 Aug; 8():127. PubMed ID: 23972085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant Peripheral Nerve Sheath Tumor.
    James AW; Shurell E; Singh A; Dry SM; Eilber FC
    Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience of a single center in the treatment of rare malignant peripheral nerve sheath tumors during the years 1991-2021.
    Ptchelintseva A; Nuutinen H; Salo J; Tukiainen E
    J Plast Surg Hand Surg; 2023; 57(1-6):376-382. PubMed ID: 36244030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation.
    Carlson ML; Jacob JT; Habermann EB; Glasgow AE; Raghunathan A; Link MJ
    J Neurosurg; 2016 Nov; 125(5):1120-1129. PubMed ID: 26745487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic Options for Malignant Peripheral Nerve Sheath Tumors.
    Hassan A; Pestana RC; Parkes A
    Curr Treat Options Oncol; 2021 Feb; 22(4):33. PubMed ID: 33641042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
    Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
    Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
    Ziadi A; Saliba I
    Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
    Kolberg M; Høland M; Agesen TH; Brekke HR; Liestøl K; Hall KS; Mertens F; Picci P; Smeland S; Lothe RA
    Neuro Oncol; 2013 Feb; 15(2):135-47. PubMed ID: 23161774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.